Publication | Closed Access
G3139 (Genasense) in Patients With Advanced Merkel Cell Carcinoma
46
Citations
30
References
2009
Year
Bcl-2 antisense therapy (G3139) was well tolerated among patients with advanced MCC. Although probable antitumor activity was documented in 1 patient, no objective responses per Response Evaluation Criteria in Solid Tumors criteria were observed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1